Vaccines
Myco-Bac® Vaccines
Contains: Mycoplasma bovis vaccine
INDICATIONS
Mycoplasma bovis is one of the most prevalent of all the bacterial pathogens affecting young cattle during periods of elevated stress such as weaning and transportation. In general, the higher the “risk classification” of a particular group of cattle the greater the possibility of a Mycoplasma problem.
The typical “myco” infections begin to show up about 3 weeks after exposure and can cause respiratory disease as well as crippling arthritis. Due to it’s extremely small cell size and lack of a ridged cell wall, many antibiotics are rendered ineffective against M. bovis resulting in increased pull rates, poor treatment response and unusually high death rates.
MYCO-BAC® was the first fully licensed Mycoplasma bovis (also referred to as ‘Mycoplasma’ or ‘Myco’) vaccine approved by the USDA in 2002. It was originally developed by the team at Texas Vet Lab, Inc. following years of clinical observation and diagnostic/laboratory research as well as significant experience producing effective autogenous vaccines for feedlot and stocker veterinarians and consultants from across the country.
PACK SIZES
50 dose vials
100 dose vials
Disclaimer
Please be aware that product specifications and availability can differ between countries. Not all products are available in every country and SPCS/ indications may vary between country. For more detailed information in this regard, we invite you to contact us. Any sample marketing materials and data sheets shown on this page are for illustrative purposes only, and may not be accurate for your country of interest.
